ometendoОжирение и метаболизмObesity and metabolism2071-87132306-5524Endocrinology Research Centre10.14341/2071-8713-4798ometendo-4798Research ArticleСтатьиArticlesОткрытое исследование эффективности и безопасности терапии орлистатом (Ксеникалом) у женщин с метаболическим синдромом в постменопаузеOtkrytoe issledovanie effektivnosti i bezopasnosti terapii orlistatom (Ksenikalom) u zhenshchin s metabolicheskim sindromom v postmenopauzeKhoroshevaG A-Mel'nichenkoG A-RomantsovaT I-IzmozherovaN V-PopovA A-20051503200521№1 (2005)812Copyright © Khorosheva G.A., Mel'nichenko G.A., Romantsova T.I., Izmozherova N.V., Popov A.A., 20052005Khorosheva G.A., Mel'nichenko G.A., Romantsova T.I., Izmozherova N.V., Popov A.A.Khorosheva G.A., Mel'nichenko G.A., Romantsova T.I., Izmozherova N.V., Popov A.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.omet-endojournals.ru/jour/article/view/4798ReferencesHauptman J. Orlistat: Selective inhibition of caloric absorption can effect long term body weight. - Endocrine, 2000;13:201-206.Hauptman J. Orlistat: Selective inhibition of caloric absorption can effect long term body weight. - Endocrine, 2000;13:201-206.Krauss RM, Winston M. Obesity: impact on cardiovascular disease. Circulation. 1998; 98;1472-6.Krauss RM, Winston M. Obesity: impact on cardiovascular disease. Circulation. 1998; 98;1472-6.National Institutes of Health: National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. 1998.National Institutes of Health: National Heart, Lung, and Blood Institute. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults. 1998.Nisoli E, Carruba MO. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mecchanism of action. Obes Rev 2000;1:127-39.Nisoli E, Carruba MO. An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mecchanism of action. Obes Rev 2000;1:127-39.Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.The Writing Group for the ISCD Position Development Conference 2004/ Executive Summary: International Society for Clinical Dencitometry Position Development Conference, Cincinnati Ohio. / J. Clin. Dencitom.7. p.p. 7-12.The Writing Group for the ISCD Position Development Conference 2004/ Executive Summary: International Society for Clinical Dencitometry Position Development Conference, Cincinnati Ohio. / J. Clin. Dencitom.7. p.p. 7-12.World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, Switzerland: 1998.World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, Switzerland: 1998.
The authors declare that there are no conflicts of interest present.